AVITA MedicalASX:AVH -2.25%57 Market Cap is A$167.0 Mil as of Jun. 26, 2026. GuruFocus rates ASX:AVH with a GF Score™ of 57/100 and a GF Value™ of A$3.05 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 866 Medical Devices & Instruments companies, AVITA Medical ranks worse than 50.12% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). AVITA Medical's share price for the quarter that ended in Mar. 2026 was A$1.075. AVITA Medical's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 153.9 Mil. Therefore, AVITA Medical's market cap for the quarter that ended in Mar. 2026 was A$165.4 Mil.
AVITA Medical's quarterly market cap
declined
from Sep. 2025 (A$247.0 Mil) to Dec. 2025 (A$160.5 Mil) but then
increased
from Dec. 2025 (A$160.5 Mil) to Mar. 2026 (A$165.4 Mil).
AVITA Medical's annual market cap
increased
from Dec. 2023 (A$550.9 Mil) to Dec. 2024 (A$560.0 Mil) but then
declined
from Dec. 2024 (A$560.0 Mil) to Dec. 2025 (A$160.5 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. AVITA Medical's Enterprise Value for Today is A$215.0 Mil.
AVITA Medical (ASX:AVH) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
AVITA Medical Market Cap Related Terms
AVITA Medical Market Cap Historical Data
* Premium members only.
The historical data trend for AVITA Medical's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:AVH vs NNOX, MXCT, SNWV: Market Cap Comparison
For the Medical Devices subindustry, AVITA Medical's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AVITA Medical Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, AVITA Medical's Market Cap distribution charts can be found below:
* The bar in red indicates where AVITA Medical's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
AVITA Medical's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AVITA Medical (ASX:AVH) has a Market Cap of A$167.0 Mil as of Jun. 26, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on AVITA Medical and its competitors. According to the industry distribution chart, AVITA Medical ranks #434 out of 866 companies in the Medical Devices & Instruments industry, placing it in the top 50.1%.
Is AVITA Medical's Market Cap too high?
AVITA Medical's current Market Cap is A$167.0 Mil. Based on the distribution chart, AVITA Medical ranks #434 out of 866 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, AVITA Medical has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does AVITA Medical's Market Cap compare to NNOX and MXCT?
According to the Medical Devices & Instruments industry distribution chart, AVITA Medical ranks #434 out of 866 companies for Market Cap. This places AVITA Medical in the lower half of its industry. The industry median Market Cap is 121.29. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 121.29, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on AVITA Medical and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 121.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AVITA Medical's current Market Cap is A$167.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AVITA Medical stock overvalued right now?
Based on GuruFocus' analysis, AVITA Medical (ASX:AVH) is currently considered Possible Value Trap. The stock's GF Value™ is A$3.05, compared to a current price of A$1.09 — trading 64.4% below its estimated fair value. The current Market Cap is A$167.0 Mil. AVITA Medical's overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For AVITA Medical (ASX:AVH), the current Market Cap is A$167.0 Mil as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AVITA Medical (ASX:AVH) Overvalued in 2026?
Based on GuruFocus' analysis, AVITA Medical stock appears to be undervalued.
The current stock price of A$1.09 is trading 64.4% below its estimated GF Value™ of A$3.05.
GuruFocus considers AVITA Medical to be Possible Value Trap.
Key valuation signals for ASX:AVH:
Market Cap: A$167.0 Mil
GF Value™: A$3.05 vs. price of A$1.09 (64.4% below fair value)
No single metric tells the full story. See the ASX:AVH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.
57GF Score
Get the complete analysis for ASX:AVH
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:AVH has been successfully added to your 
